Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1988 Jul;62(7):2483–2489. doi: 10.1128/jvi.62.7.2483-2489.1988

Humoral and cellular immune responses to matrix protein of measles virus in subacute sclerosing panencephalitis.

S Dhib-Jalbut 1, H F McFarland 1, E S Mingioli 1, J L Sever 1, D E McFarlin 1
PMCID: PMC253407  PMID: 3373575

Abstract

The immune response to matrix (M) protein of measles virus was examined in patients with subacute sclerosing panencephalitis (SSPE) and controls. Antibodies specific for M and nucleocapsid (NC) proteins in 11 serum and 8 cerebrospinal fluid (CSF) samples from patients with SSPE were quantitated by enzyme-linked immunosorbent assay by using affinity-purified measles virus proteins. Geometric mean anti-NC antibody titers were higher in the serum (6.58 +/- 0.98 [mean +/- standard deviation]) and CSF (4.38 +/- 0.74) of SSPE patients compared with controls. Anti-M antibodies were present in the serum and CSF of all SSPE samples tested but in titers lower than those of anti-NC antibodies. Geometric mean anti-M antibody titer was 3.35 +/- 0.53 in sera from patients with SSPE compared with 3.05 +/- 0.66 in sera from patients with other neurological diseases and 3.12 +/- 0.74 in sera from healthy individuals. Geometric mean anti-M antibody titer was 2.59 +/- 0.86 in the CSF of eight patients with SSPE compared with a mean less than 1.00 for patients with other neurological disease (controls). Intrathecal synthesis of anti-M or anti-NC antibodies was established in four patients with SSPE. The cellular immune responses to M, F, HA, and NC proteins were examined in four of the patients with SSPE by lymphoproliferation and were not significantly different from those in five healthy controls. The results demonstrate humoral and cellular immune responses to M protein in patients with SSPE and indicate that it is unlikely that a defect in the immune response to this virus component accounts for the disease process in the patients studied.

Full text

PDF
2488

Images in this article

2485Image
on p.2485

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Axén R., Porath J., Ernback S. Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides. Nature. 1967 Jun 24;214(5095):1302–1304. doi: 10.1038/2141302a0. [DOI] [PubMed] [Google Scholar]
  2. Bellini W. J., McFarlin D. E., Silver G. D., Mingioli E. S., McFarland H. F. Immune reactivity of the purified hemagglutinin of measles virus. Infect Immun. 1981 Jun;32(3):1051–1057. doi: 10.1128/iai.32.3.1051-1057.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Graziano K. D., Ruckdeschel J. C., Mardiney M. R., Jr Cell-associated immunity to measles (rubeola). The demonstration of in vitro lymphocyte tritiated thymidine incorporation in response to measels complement fixation antigen. Cell Immunol. 1975 Feb;15(2):347–359. doi: 10.1016/0008-8749(75)90013-1. [DOI] [PubMed] [Google Scholar]
  4. Hall W. W., Lamb R. A., Choppin P. W. Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis. Proc Natl Acad Sci U S A. 1979 Apr;76(4):2047–2051. doi: 10.1073/pnas.76.4.2047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Horta-Barbosa L., Fuccillo D. A., Sever J. L., Zeman W. Subacute sclerosing panencephalitis: isolation of measles virus from a brain biopsy. Nature. 1969 Mar 8;221(5184):974–974. doi: 10.1038/221974a0. [DOI] [PubMed] [Google Scholar]
  6. Ilonen J., Reunanen M., Herva E., Ziola B., Salmi A. Stimulation of lymphocytes from subacute sclerosing panencephalitis patients by defined measles virus antigens. Cell Immunol. 1980 May;51(2):201–214. doi: 10.1016/0008-8749(80)90253-1. [DOI] [PubMed] [Google Scholar]
  7. Jacobson S., Flerlage M. L., McFarland H. F. Impaired measles virus-specific cytotoxic T cell responses in multiple sclerosis. J Exp Med. 1985 Sep 1;162(3):839–850. doi: 10.1084/jem.162.3.839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Johnson R. T., Griffin D. E., Hirsch R. L., Wolinsky J. S., Roedenbeck S., Lindo de Soriano I., Vaisberg A. Measles encephalomyelitis--clinical and immunologic studies. N Engl J Med. 1984 Jan 19;310(3):137–141. doi: 10.1056/NEJM198401193100301. [DOI] [PubMed] [Google Scholar]
  9. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  10. McFarland H. F., McFarlin D. E. Cellular immune response to measles, mumps, and vaccinia viruses in multiple sclerosis. Ann Neurol. 1979 Aug;6(2):101–106. doi: 10.1002/ana.410060204. [DOI] [PubMed] [Google Scholar]
  11. Moulias R. L., Reinert P., Goust J. M. Immunologic abnormalities in subacute sclerosing panencephalitis. N Engl J Med. 1971 Nov 4;285(19):1090–1090. [PubMed] [Google Scholar]
  12. Norrby E., Orvell C., Vandvik B., Cherry J. D. Antibodies against measles virus polypeptides in different disease conditions. Infect Immun. 1981 Dec;34(3):718–724. doi: 10.1128/iai.34.3.718-724.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Payne F. E., Baublis J. V., Itabashi H. H. Isolation of measles virus from cell cultures of brain from a patient with subacute sclerosing panencephalitis. N Engl J Med. 1969 Sep 11;281(11):585–589. doi: 10.1056/NEJM196909112811103. [DOI] [PubMed] [Google Scholar]
  14. Rose J. W., Bellini W. J., McFarlin D. E., McFarland H. F. Human cellular immune response to measles virus polypeptides. J Virol. 1984 Mar;49(3):988–991. doi: 10.1128/jvi.49.3.988-991.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rozenblatt S., Gorecki M., Shure H., Prives C. L. Characterization of measles virus-specific proteins synthesized in vivo and in vitro from acutely and persistently infected cells. J Virol. 1979 Mar;29(3):1099–1016. doi: 10.1128/jvi.29.3.1099-1106.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Saunders M., Chambers M. E., Knowles M., Caspary E. A., Gardner-Medwin D., Walker P. Cellular and humoral responses to measles in subacute sclerosing panencephalitis. Lancet. 1969 Jan 11;1(7585):72–74. doi: 10.1016/s0140-6736(69)91090-3. [DOI] [PubMed] [Google Scholar]
  17. Sundar S. K., Barile G., Menezes J. Isoprinosine enhances the activation of sensitized lymphocytes by Epstein-Barr virus antigens. Int J Immunopharmacol. 1985;7(2):187–192. doi: 10.1016/0192-0561(85)90025-6. [DOI] [PubMed] [Google Scholar]
  18. Thurman G. B., Ahmed A., Strong D. M., Knudsen R. C., Grace W. R., Sell K. W. Lymphocyte activation in subacute sclerosing panencephalitis virus and cytomegalovirus infections. In vitro stimulation in response to viral-infected cell lines. J Exp Med. 1973 Oct 1;138(4):839–846. doi: 10.1084/jem.138.4.839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Trudgett A., Bellini W. J., Mingioli E. S., McFarlin D. E. Antibodies to the structural polypeptides of measles virus following acute infection and in SSPE. Clin Exp Immunol. 1980 Mar;39(3):652–656. [PMC free article] [PubMed] [Google Scholar]
  20. Tsang K. Y., Pan J. F., Swanger D. L., Fudenberg H. H. In vitro restoration of immune responses in aging humans by isoprinosine. Int J Immunopharmacol. 1985;7(2):199–206. doi: 10.1016/0192-0561(85)90027-x. [DOI] [PubMed] [Google Scholar]
  21. Valdimarsson H., Agnarsdottir G., Lachmann P. J. Cellular immunity in subacute sclerosing panencephalitis. Proc R Soc Med. 1974 Nov;67(11):1125–1129. [PMC free article] [PubMed] [Google Scholar]
  22. Wechsler S. L., Weiner H. L., Fields B. N. Immune response in subacute sclerosing panencephalitis: reduced antibody response to the matrix protein of measles virus. J Immunol. 1979 Aug;123(2):884–889. [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES